| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.43B | +8.7% |
| Cost of Revenue | $913.0M | +6.7% |
| Gross Profit | $516.7M | +12.6% |
| R&D Expense | $19.9M | -2.9% |
| SG&A Expense | $247.3M | +0.9% |
| Operating Income | $260.6M | +43.4% |
| Interest Expense | $20.0M | -7.0% |
| Pre-tax Income | $254.2M | +55.6% |
| Income Tax | $62.5M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $211.9M | +1.4% |
| Inventory | $328.7M | +8.9% |
| Current Assets | $1.03B | +19.9% |
| Total Assets | $1.84B | +12.4% |
| Current Liabilities | $290.3M | +12.5% |
| Long-term Debt | $450.4M | +0.4% |
| Total Liabilities | $857.2M | +3.8% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $219.3M | -8.2% |
| Investing Cash Flow | -$47.1M | +0.2% |
| Financing Cash Flow | -$58.3M | -26.7% |
| +31.6% |
| Net Income | $191.7M | +65.4% |
| EPS (Basic) | $1.23 | +66.2% |
| EPS (Diluted) | $1.22 | +64.9% |
| Stockholders' Equity |
| $981.7M |
| +21.2% |